This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Wi
When you call, don't forget to mention that you found this ad on I do not wish to be contacted by telemarketers or representatives of any other website.